RxDoctor Payments Data

Daniel Sharkey, MD

Otolaryngology/Facial Plastic Surgery · Stuart, FLNPI 1952377780

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 3 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 59.9% of the total. 2025 is the largest year on record at $171, more than ten times the $11 reported in 2019. That places this record below the midpoint for otolaryngology/facial plastic surgery clinicians in FL, where the typical reported total is $2,474.

$272in general payments, 2019–2025

Across 11 payments — averaging $24.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$163
  • Sanofi$98
  • Smith+Nephew$11

What the payments were for

  • Food & beverage$272100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$272 in reported general payments places this provider in the 10th percentile of 48 otolaryngology/facial plastic surgery providers in Florida.

See all otolaryngology/facial plastic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$283,949
Medicare patients
1,280
Services billed
3,462

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide34$803
Fluticasone Propionate41$774
Azelastine Hcl18$589
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav20$281
Omeprazole13$136
Prednisone41$134
Diazepam12$51

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Stuart

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →